Monitoring of minimal residual disease (MRD) is useful to predict prognosis of adult patients with Ph-negative ALL: results of a prospective study (ALL MRD2002 Study)

<p>Abstract</p> <p>Background</p> <p>Allogeneic hematopoietic stem cell transplantation (HSCT) for patients with Philadelphia chromosome (Ph)-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR1) is much more intensive than multi-agent combined c...

Full description

Bibliographic Details
Main Authors: Nagafuji Koji, Miyamoto Toshihiro, Eto Tetsuya, Kamimura Tomohiko, Taniguchi Shuichi, Okamura Takashi, Ohtsuka Eiichi, Yoshida Takashi, Higuchi Masakazu, Yoshimoto Goichi, Fujisaki Tomoaki, Abe Yasunobu, Takamatsu Yasushi, Yokota Shouhei, Akashi Koichi, Harada Mine
Format: Article
Language:English
Published: BMC 2013-02-01
Series:Journal of Hematology & Oncology
Subjects:
Online Access:http://www.jhoonline.org/content/6/1/14